The European Lead Factory selects first COVID-19 proposal
Over the last few months, as the world has grappled with the COVID-19 pandemic, the European Lead Factory has been
Knowledge for Growth 2020 – 9 & 10 September
Celebrating the 16th Knowledge for Growth event. Meet PPSC virtually at the first digital Knowledge for Growth conference.
One of the sub-projects of the MMV-PDP Consortium recently received funding from the Bill and Melinda Gates Foundation, to further develop an
ZeGlobalTox – a rapid and reliable preclinical screening tool
The zebrafish (Danio rerio) is a tropical fish with a genetic structure surprisingly similar to ours. However, they’ve become a
Novel Screening Assay for Arginase-1 Inhibitors published in SLAS Discovery
Arginase-1 is a promising new drug target for cancer immunotherapy. A novel assay technology for High-Throughput Screening (HTS) of Arginase-1
NTRC publishes High-Throughput Screening assay for IDO1 and TDO in Journal of Biomolecular Screening
Immunotherapy is one of the recent advances in cancer treatment. Cancer immunotherapy makes use of the body’s immune system to
Committed to strengthening the antibiotic arsenal
The European Lead Factory (ELF) is boosting the discovery of new drugs by making High-Throughput Screening and a quality compound
Pivot Park – Banting Building (RE2423)
Kloosterstraat 9
5349 AB Oss
The Netherlands
Pivot Park – RE2423
Industrielaan 63
5349 AE Oss
The Netherlands
